Shaobo Ke
Wuhan University
15 Papers
8 Citations
Shaobo Ke is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)
Wensi Zhao,Jun Lei,Shaobo Ke,Yuan Chen,Jiping Xiao,Ze Tang,Li Wang,Yiping Ren,Mohammed Alnaggar,Hu Qiu,Wei Shi,Lei Yin,Yongshun Chen +12 more
TL;DR: FMT plus tislelizumab and fruquintinib as third-line or above treatment showed improved survival and manageable safety in refractory MSS mCRC, suggesting a valuable new treatment option for this patient population.
30
Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.
Hui Yang,Lin Wu,Shaobo Ke,Wenbo Wang,Lei Yang,Xiaojia Gao,Hongyan Fang,Haijun Yu,Yahua Zhong,Conghua Xie,Fuxiang Zhou,Yunfeng Zhou +11 more
TL;DR: It is demonstrated that UBE2D3 downregulation enhances radioresistance by increased telomere homeostasis and prolonged IR-induced G2/M arrest, but decreases the IR- induced apoptosis and the number of DNA damage foci.
Radiotherapy plus camrelizumaband irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial.
Wensi Zhao,Shaobo Ke,Xiaojun Cai,Zhi Zuo,Wei Shi,Hu Qiu,Gaoke Cai,Ying Gong,Yusheng Wu,Shasha Ruan,Yongshuo Chen +10 more
TL;DR: In this paper , the authors evaluated the efficacy and safety of low-dose radiotherapy plus immunotherapy and second-line chemotherapy in oligometastatic esophageal squamous cell carcinoma (ESCC).
16
Regional Lymph Node Metastasis and Axillary Surgery of Microinvasive Breast Cancer: A Population-Based Study
Jia-Mei Chen,B. Luo,Meng-Ting Gao,Gaoke Cai,Xixi Luo,Yutian Zhang-Cai,Shaobo Ke,Yongshuo Chen +7 more
TL;DR: It is demonstrated that the vast majority of MBC have a low LNM rate and excellent prognosis; patients with LNM showed poor prognosis.
A Comparison of Clinicopathologic Outcomes and Patterns of Lymphatic Spread Across Neoadjuvant Chemotherapy, Neoadjuvant Chemoradiotherapy, and Neoadjuvant Immunochemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
Yuanyuan Tian,Zhenguo Shi,Chenyu Wang,Shaobo Ke,Huifen Qiu,Wensi Zhao,Yong Wu,Jiamei Chen,Yaowen Zhang,Yongshuo Chen +9 more
TL;DR: NCRT or NICT followed by surgery may result in a promising pCR rate and show a better performance in therapeutic response of primary lesion and for patients with lymph node metastasis in station 1R and 2R, NCRT should be the optimal preoperative treatment strategy.
8